Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Neurol Sci ; 45(6): 2811-2823, 2024 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-38194197

RESUMEN

OBJECTIVE: As autoimmune encephalitis (AE) often involves the mesial temporal structures which are known to be involved in both sudden unexpected death in epilepsy (SUDEP) and ictal asystole (IA), it may represent a good model to study the physiopathology of these phenomena. Herein, we systematically reviewed the occurrence of SUDEP and IA in AE. METHODS: We searched 4 databases (MEDLINE, Scopus, Embase, and Web of Science) for studies published between database inception and December 20, 2022, according to the PRISMA guidelines. We selected articles reporting cases of definite/probable/possible/near-SUDEP or IA in patients with possible/definite AE, or with histopathological signs of AE. RESULTS: Of 230 records assessed, we included 11 cases: 7 SUDEP/near-SUDEP and 4 IA. All patients with IA were female. The median age at AE onset was 30 years (range: 15-65), and the median delay between AE onset and SUDEP was 11 months; 0.9 months for IA. All the patients presented new-onset seizures, and 10/11 also manifested psychiatric, cognitive, or amnesic disorders. In patients with SUDEP, 2/7 were antibody-positive (1 anti-LGI1, 1 anti-GABABR); all IA cases were antibody-positive (3 anti-NMDAR, 1 anti-GAD65). Six patients received steroid bolus, 3 intravenous immunoglobulin, and 3 plasmapheresis. A pacemaker was implanted in 3 patients with IA. The 6 survivors improved after treatment. DISCUSSION: SUDEP and IA can be linked to AE, suggesting a role of the limbic system in their pathogenesis. IA tends to manifest in female patients with temporal lobe seizures early in AE, highlighting the importance of early diagnosis and treatment.


Asunto(s)
Encefalitis , Paro Cardíaco , Muerte Súbita e Inesperada en la Epilepsia , Humanos , Encefalitis/complicaciones , Encefalitis/fisiopatología , Paro Cardíaco/complicaciones , Paro Cardíaco/mortalidad , Enfermedad de Hashimoto/complicaciones , Enfermedad de Hashimoto/fisiopatología , Femenino , Adolescente , Adulto , Epilepsia/complicaciones , Epilepsia/mortalidad , Epilepsia/fisiopatología , Adulto Joven , Persona de Mediana Edad
2.
Molecules ; 27(15)2022 Jul 28.
Artículo en Inglés | MEDLINE | ID: mdl-35956787

RESUMEN

Specialized pro-resolving mediators (SPMs) are lipid mediators derived from poly-unsaturated fatty acids (PUFAs) which have been demonstrated to have an important role in the inflammation environment, preventing an overreaction of the organism and promoting the resolution of inflammation. Our purpose was to point out the current evidence for specialized pro-resolving mediators, focusing on their role in neuroinflammation and in major neurological diseases.


Asunto(s)
Eicosanoides , Enfermedades Neuroinflamatorias , Ácidos Docosahexaenoicos , Ácidos Grasos Insaturados/uso terapéutico , Humanos , Inflamación/tratamiento farmacológico , Mediadores de Inflamación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA